Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-020163
Filing Date
2021-03-12
Accepted
2021-03-12 16:26:42
Documents
2
Period of Report
2020-04-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1592
2 POA DOCUMENT poa.txt EX-24.3_972646 3596
  Complete submission text file 0001209191-21-020163.txt   6685
Mailing Address 5 KIRYAT HAMADA ST PO BOX 45032 JERUSALEM L3 9777401
Business Address 5 KIRYAT HAMADA ST PO BOX 45032 JERUSALEM L3 9777401 972-2-5486555
Anchiano Therapeutics Ltd. (Issuer) CIK: 0001534248 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE KENDALL SQUARE BUILDING 1400E, SUITE 14-105 CAMBRIDGE MA 02139
Business Address
Polovets Stanislav (Reporting) CIK: 0001847625 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38807 | Film No.: 21737783